ROCURONIUM BROMIDE

ROCURONIUM BROMIDE- rocuronium bromide injection, solution
HF Acquisition Co LLC, DBA HealthFirst

HIGHLIGHTS OF PRESCRIBING INFORMATION


These highlights do not include all the information needed to use ROCURONIUM BROMIDE INJECTION safely and effectively. See full prescribing information for ROCURONIUM BROMIDE INJECTION.
ROCURONIUM BROMIDE injection, solution for intravenous use
Initial U.S. Approval: 1994

RECENT MAJOR CHANGES

Dosage and Administration

Important Dosing and Administration Information (2.1) 07/2018

Warnings and Precautions

Risk of Death due to Medication Errors ( 5.3) 07/2018

INDICATIONS AND USAGE

Rocuronium bromide injection is a nondepolarizing neuromuscular blocking agent indicated as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. (1)

DOSAGE AND ADMINISTRATION

To be administered only by experienced clinicians or adequately trained individuals supervised by an experienced clinician familiar with the use, actions, characteristics, and complications of neuromuscular blocking agents. ( 2.1)

Individualize the dose for each patient. (2.1)
Peripheral nerve stimulator recommended for determination of drug response and need for additional doses, and to evaluate recovery. ( 2.1)
Store Rocuronium bromide injection with cap and ferrule intact and in a manner that minimizes the possibility of selecting the wrong product. ( 2.1)
Tracheal intubation: Recommended initial dose is 0.6 mg/kg. ( 2.2)
Rapid sequence intubation: 0.6 to 1.2 mg/kg. ( 2.3)
Maintenance doses: Guided by response to prior dose, not administered until recovery is evident. ( 2.4)
Continuous infusion: Initial rate of 10 to 12 mcg/kg/min. Start only after early evidence of spontaneous recovery from an intubating dose. ( 2.5)

DOSAGE FORMS AND STRENGTHS

5 mL multiple dose vials containing 50 mg rocuronium bromide injection (10 mg/mL). ( 3)
10 mL multiple dose vials containing 100 mg rocuronium bromide injection (10 mg/mL). ( 3)

CONTRAINDICATIONS

Hypersensitivity (e.g., anaphylaxis) to rocuronium bromide or other neuromuscular blocking agents. ( 4)

WARNINGS AND PRECAUTIONS

Appropriate Administration and Monitoring: Use only if facilities for intubation, mechanical ventilation, oxygen therapy, and an antagonist are immediately available. ( 5.1)
Anaphylaxis: Severe anaphylaxis has been reported. Consider cross-reactivity among neuromuscular blocking agents. ( 5.2)
Risk of Death due to Medication Errors: Accidental administration can cause death. ( 5.3)
Need for Adequate Anesthesia: Must be accompanied by adequate anesthesia or sedation. ( 5.4)
Residual Paralysis: Consider using a reversal agent in cases where residual paralysis is more likely to occur. ( 5.5)

ADVERSE REACTIONS

Most common adverse reactions (2%) are transient hypotension and hypertension. (6)
To report SUSPECTED ADVERSE REACTIONS, contact AuroMedics Pharma LLC at 1-866-850-2876 or FDA at 1-800-FDA-1088 or WWW.FDA.GOV/MEDWATCH.

DRUG INTERACTIONS

Succinylcholine: Use before succinylcholine has not been studied. ( 7.11)
Nondepolarizing muscle relaxants: Interactions have been observed. ( 7.7)
Enhanced rocuronium bromide activity possible: Inhalation anesthetics ( 7.3), certain antibiotics ( 7.1), quinidine ( 7.10), magnesium ( 7.6), lithium ( 7.4), local anesthetics ( 7.5), procainamide ( 7.8)
Reduced rocuronium bromide activity possible: Anticonvulsants. ( 7.2)

USE IN SPECIFIC POPULATIONS

Labor and Delivery: Not recommended for rapid sequence induction in patients undergoing Cesarean section. ( 8.2)
Pediatric Use: Onset time and duration will vary with dose, age, and anesthetic technique. Not recommended for rapid sequence intubation in pediatric patients. ( 8.4)

See 17 for PATIENT COUNSELING INFORMATION.

Revised: 11/2018

TABLE OF CONTENTS

FULL PRESCRIBING INFORMATION: CONTENTS*
1 INDICATIONS AND USAGE
2 DOSAGE AND ADMINISTRATION
2.1 Important Dosing and Administration Information
2.2 Dose for Tracheal Intubation
2.3 Rapid Sequence Intubation
2.4 Maintenance Dosing
2.5 Use by Continuous Infusion
2.6 Dosage in Specific Populations
2.7 Preparation for Administration of Rocuronium Bromide Injection
3 DOSAGE FORMS AND STRENGTHS
4 CONTRAINDICATIONS
5 WARNINGS AND PRECAUTIONS
5.1 Appropriate Administration and Monitoring
5.2 Anaphylaxis
5.3 Risk of Death due to Medication Errors
5.4 Need for Adequate Anesthesia
5.5 Residual Paralysis
5.6 Long-Term Use in an Intensive Care Unit
5.7 Malignant Hyperthermia (MH)
5.8 Prolonged Circulation Time
5.9 QT Interval Prolongation
5.10 Conditions/Drugs Causing Potentiation of, or Resistance to, Neuromuscular Block
5.11 Incompatibility with Alkaline Solutions
5.12 Increase in Pulmonary Vascular Resistance
5.13 Use in Patients with Myasthenia
5.14 Extravasation
6 ADVERSE REACTIONS
6.1 Clinical Trials Experience
6.2 Postmarketing Experience
7 DRUG INTERACTIONS
7.1 Antibiotics
7.2 Anticonvulsants
7.3 Inhalation Anesthetics
7.4 Lithium Carbonate
7.5 Local Anesthetics
7.6 Magnesium
7.7 Nondepolarizing Muscle Relaxants
7.8 Procainamide
7.9 Propofol
7.10 Quinidine
7.11 Succinylcholine
8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
8.2 Labor and Delivery
8.4 Pediatric Use
8.5 Geriatric Use
8.6 Patients with Hepatic Impairment
8.7 Patients with Renal Impairment
10 OVERDOSAGE
11 DESCRIPTION
12 CLINICAL PHARMACOLOGY
12.1 Mechanism of Action
12.2 Pharmacodynamics
12.3 Pharmacokinetics
13 NONCLINICAL TOXICOLOGY
13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
14 CLINICAL STUDIES
14.1 Adult Patients
14.2 Geriatric Patients
14.3 Pediatric Patients
16 HOW SUPPLIED/STORAGE AND HANDLING
17 PATIENT COUNSELING INFORMATION

*
Sections or subsections omitted from the full prescribing information are not listed.

1 INDICATIONS & USAGE

Rocuronium bromide injection is indicated for inpatients and outpatients as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.